SCIENTURE HOLDINGS, INC. Amortization of Intangible Assets
SCIENTURE HOLDINGS, INC. (SCNX) reported Amortization of Intangible Assets of $907.69 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-13
- SCIENTURE HOLDINGS, INC. amortization of intangible assets for the quarter ending 2026-06-30 was $453.85K.
- SCIENTURE HOLDINGS, INC. amortization of intangible assets for the quarter ending 2026-03-31 was $453.85K.
- SCIENTURE HOLDINGS, INC. amortization of intangible assets for the quarter ending 2023-12-31 was $488.87K, a 3225.67% increase year-over-year.
- SCIENTURE HOLDINGS, INC. amortization of intangible assets for the quarter ending 2022-12-31 was $14.70K.
- SCIENTURE HOLDINGS, INC. amortization of intangible assets for fiscal 2023 was $814.79K, a 1747.60% increase from fiscal 2022.
- SCIENTURE HOLDINGS, INC. amortization of intangible assets for fiscal 2022 was $44.10K.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $453.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $907.69K 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | $453.85K 10-Q · filed 2026-05-15 | ||||
| 2025-12-31 | $907.69K 10-Q · filed 2026-05-15 | $453.85K 10-K · filed 2026-03-30 | |||
| 2023-12-31 | $488.87K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $814.79K 10-K · filed 2025-03-26 | |||
| 2023-09-30 | $325.92K 10-Q · filed 2024-01-16 | ||||
| 2022-12-31 | $14.70K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $29.40K derived: sum of 2 quarters · filed 2024-01-16 | $44.10K 10-K · filed 2023-03-27 | ||
| 2022-09-30 | $14.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-01-16 | $29.40K 10-Q · filed 2024-01-16 | |||
| 2022-06-30 | $14.70K 10-Q · filed 2023-08-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |